Cargando…

State of the Art in Capsule-Based Dry Powder Inhalers: Deagglomeration Techniques and the Consequences for Formulation Aerosolization

Commercially available dry powder inhalers (DPIs) are usually devices in a fixed combination with the intended formulation, and a change in medication by the physician often forces the patient to use a different device, requiring the patient to relearn how to use it, resulting in lower adherence and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Groß, Roman, Berkenfeld, Kai, Schulte, Christoph, Ebert, Anselm, Sule, Sunita, Sule, Ameet, Lamprecht, Alf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230934/ https://www.ncbi.nlm.nih.gov/pubmed/35745758 http://dx.doi.org/10.3390/pharmaceutics14061185

Ejemplares similares

Deagglomeration of DNA nanomedicine carriers using controlled ultrasonication
por: Hinchliffe, Beth A., et al.
Publicado: (2022)

Understanding the Importance of Capsules in Dry Powder Inhalers
por: Buttini, Francesca, et al.
Publicado: (2021)

Deagglomeration of Ultrafine Hydrophilic Nanopowder Using Low-Frequency Pulsed Fluidization
por: Al-Ghurabi, Ebrahim H., et al.
Publicado: (2020)

Amorphicity and Aerosolization of Soluplus-Based Inhalable Spray Dried Powders
por: Adhikari, Bishal Raj, et al.
Publicado: (2022)

Recent advances in capsule-based dry powder inhaler technology
por: Lavorini, Federico, et al.
Publicado: (2017)

Simultaneous Spray Drying for Combination Dry Powder Inhaler Formulations
por: Shepard, Kimberly B., et al.
Publicado: (2022)

Radiolabeling Method for Lyophilizate for Dry Powder Inhalation Formulations
por: Miyamoto, Kahori, et al.
Publicado: (2022)

Impact of Leucine and Magnesium Stearate on the Physicochemical Properties and Aerosolization Behavior of Wet Milled Inhalable Ibuprofen Microparticles for Developing Dry Powder Inhaler Formulation
por: Sharif, Shahjabeen, et al.
Publicado: (2023)

Erratum to: Recent advances in capsule-based dry powder inhaler technology
por: Lavorini, Federico, et al.
Publicado: (2017)

A Quality by Design Framework for Capsule-Based Dry Powder Inhalers
por: Ding, Li, et al.
Publicado: (2021)

Comparison of HPMC Inhalation-Grade Capsules and Their Effect on Aerosol Performance Using Budesonide and Rifampicin DPI Formulations
por: Ding, Li, et al.
Publicado: (2022)

Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation
por: Sibum, Imco, et al.
Publicado: (2019)

Spray Dried Formulations for Inhalation—Meaningful Characterisation of Powder Properties
por: Jüptner, Angelika, et al.
Publicado: (2019)

Excipient Interactions in Glucagon Dry Powder Inhaler Formulation for Pulmonary Delivery
por: Rashid, Md Abdur, et al.
Publicado: (2019)

Puerarin dry powder inhaler formulations for pulmonary delivery: Development and characterization
por: Rashid, Md Abdur, et al.
Publicado: (2021)

Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy
por: Shao, Zitong, et al.
Publicado: (2021)

Progress on Thin Film Freezing Technology for Dry Powder Inhalation Formulations
por: Pardeshi, Sagar R., et al.
Publicado: (2022)

Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers
por: Muralidharan, Priya, et al.
Publicado: (2014)

Formulation and Biopharmaceutical Evaluation of Capsules Containing Freeze-Dried Cranberry Fruit Powder
por: Šedbarė, Rima, et al.
Publicado: (2023)

The effect of exhalation before the inhalation of dry powder aerosol drugs on the breathing parameters, emitted doses and aerosol size distributions
por: Farkas, Árpád, et al.
Publicado: (2023)

An aerosol formulation of R-salbutamol sulfate for pulmonary inhalation
por: Zhang, Xuemei, et al.
Publicado: (2014)

Development and evaluation of Chitosan nanoparticles based dry powder inhalation formulations of Prothionamide
por: Debnath, Sujit Kumar, et al.
Publicado: (2018)

POxylated Dendrimer‐Based Nano‐in‐Micro Dry Powder Formulations for Inhalation Chemotherapy
por: Restani, Rita B., et al.
Publicado: (2018)

The Optimisation of Carrier Selection in Dry Powder Inhaler Formulation and the Role of Surface Energetics
por: Abiona, Olaitan, et al.
Publicado: (2022)

Inhalable microparticles as drug delivery systems to the lungs in a dry powder formulations
por: Knap, Karolina, et al.
Publicado: (2022)

Optimization and Scale Up of Spray Dried CPZEN-45 Aerosol Powders for Inhaled Tuberculosis Treatment
por: Stewart, Ian E., et al.
Publicado: (2022)

Inhaled Edoxaban dry powder inhaler formulations: Development, characterization and their effects on the coagulopathy associated with COVID-19 infection
por: Rashid, Md Abdur, et al.
Publicado: (2021)

Ease-of-use preference for the ELLIPTA(®) dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older
por: Komase, Yuko, et al.
Publicado: (2014)

Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol delivery
por: Wu, Xiao, et al.
Publicado: (2013)

Pulmonary availability of isotretinoin in rats after inhalation of a powder aerosol
por: Raleigh, S M, et al.
Publicado: (2000)

Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler
por: Salem, HF, et al.
Publicado: (2011)

Development of an Inhaled Sustained Release Dry Powder Formulation of Salbutamol Sulphate, an Antiasthmatic Drug
por: Kumaresan, C., et al.
Publicado: (2016)

Formulation and In Vitro and In Silico Characterization of “Nano-in-Micro” Dry Powder Inhalers Containing Meloxicam
por: Party, Petra, et al.
Publicado: (2021)

Performance Testing of a Homemade Aerosol Generator for Pulmonary Administration of Dry Powder Formulations to Mice
por: Heida, Rick, et al.
Publicado: (2023)

Preparation and physicochemical characterization of spray-dried and jet-milled microparticles containing bosentan hydrate for dry powder inhalation aerosols
por: Lee, Hyo-Jung, et al.
Publicado: (2016)

Roflumilast Powders for Chronic Obstructive Pulmonary Disease: Formulation Design and the Influence of Device, Inhalation Flow Rate, and Storage Relative Humidity on Aerosolization
por: Momin, Mohammad A. M., et al.
Publicado: (2021)

Pulmonary deposition and retention of inhaled aerosols
por: Hatch, Theodore F, et al.
Publicado: (1964)

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
por: Phillips, Jonathan E., et al.
Publicado: (2017)

Inhalation of a Dry Powder Ciprofloxacin Formulation in Healthy Subjects: A Phase I Study
por: Stass, Heino, et al.
Publicado: (2013)

Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis
por: Chennakesavulu, S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_maiol2ru8kfmjk75333ccs3h2v